BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 30654820)

  • 1. Emerging roles of telomeric chromatin alterations in cancer.
    Cacchione S; Biroccio A; Rizzo A
    J Exp Clin Cancer Res; 2019 Jan; 38(1):21. PubMed ID: 30654820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomeres: Implications for Cancer Development.
    Bernal A; Tusell L
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
    Apte MS; Cooper JP
    Crit Rev Biochem Mol Biol; 2017 Feb; 52(1):57-73. PubMed ID: 27892716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere Length Dynamics and the Evolution of Cancer Genome Architecture.
    Cleal K; Norris K; Baird D
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin regulation and non-coding RNAs at mammalian telomeres.
    Schoeftner S; Blasco MA
    Semin Cell Dev Biol; 2010 Apr; 21(2):186-93. PubMed ID: 19815087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guarding chromosomes from oxidative DNA damage to the very end.
    Tan R; Lan L
    Acta Biochim Biophys Sin (Shanghai); 2016 Jul; 48(7):617-22. PubMed ID: 27174872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
    Sobinoff AP; Pickett HA
    Trends Genet; 2017 Dec; 33(12):921-932. PubMed ID: 28969871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
    Zhao S; Wang F; Liu L
    Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere dysfunction and genome instability.
    Frias C; Pampalona J; Genesca A; Tusell L
    Front Biosci (Landmark Ed); 2012 Jun; 17(6):2181-96. PubMed ID: 22652771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative lengthening of telomeres in cancer stem cells in vivo.
    Bojovic B; Booth RE; Jin Y; Zhou X; Crowe DL
    Oncogene; 2015 Jan; 34(5):611-20. PubMed ID: 24531712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process.
    Raynaud CM; Sabatier L; Philipot O; Olaussen KA; Soria JC
    Crit Rev Oncol Hematol; 2008 May; 66(2):99-117. PubMed ID: 18243729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeric noncoding RNA: telomeric repeat-containing RNA in telomere biology.
    Cusanelli E; Chartrand P
    Wiley Interdiscip Rev RNA; 2014; 5(3):407-19. PubMed ID: 24523222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere recombination and alternative telomere lengthening mechanisms.
    Draskovic I; Londono Vallejo A
    Front Biosci (Landmark Ed); 2013 Jan; 18(1):1-20. PubMed ID: 23276906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin structure in telomere dynamics.
    Galati A; Micheli E; Cacchione S
    Front Oncol; 2013; 3():46. PubMed ID: 23471416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of telomeric chromatin at the crossroads of aging and cancer.
    Ye J; Wu Y; Gilson E
    Essays Biochem; 2010 Sep; 48(1):147-64. PubMed ID: 20822492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New twists to the ALTernative endings at telomeres.
    Bhargava R; Lynskey ML; O'Sullivan RJ
    DNA Repair (Amst); 2022 Jul; 115():103342. PubMed ID: 35588569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers.
    Lu R; Pickett HA
    Open Biol; 2022 Mar; 12(3):220011. PubMed ID: 35259951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The number of dysfunctional telomeres in a cell: one amplifies; more than one translocate.
    Tusell L; Soler D; Agostini M; Pampalona J; GenescĂ  A
    Cytogenet Genome Res; 2008; 122(3-4):315-25. PubMed ID: 19188701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of telomeric chromatin to create ALTernative endings.
    O'Sullivan RJ; Almouzni G
    Trends Cell Biol; 2014 Nov; 24(11):675-85. PubMed ID: 25172551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.